Markets:

Overview

News

Currencies

International

Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

92.35 +1.88 (+2.08%)

Streaming Delayed Price Updated: 12:34 PM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

1 Healthcare Stock with Solid Fundamentals and 2 to Turn Down

March 21, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

How Is The Market Feeling About Globus Medical? ↗

March 19, 2025

Via Benzinga

Breaking Down Globus Medical: 5 Analysts Share Their Views ↗

March 18, 2025

Via Benzinga

Despite its growth, GLOBUS MEDICAL INC - A (NYSE:GMED) remains within the realm of affordability. ↗

March 13, 2025

Discover GLOBUS MEDICAL INC - A, an undervalued growth gem. NYSE:GMED is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing...

Via Chartmill

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

March 11, 2025

From Globus Medical

Via GlobeNewswire

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today ↗

March 03, 2025

Via Benzinga

Medical Devices & Supplies - Specialty Stocks Q4 In Review: Globus Medical (NYSE:GMED) Vs Peers

March 11, 2025

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers.

Via StockStory

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

March 06, 2025

From Globus Medical

Via GlobeNewswire

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

March 05, 2025

Monday, March 10, 2025 at 4:30 pm Pacific Time

From Globus Medical

Via GlobeNewswire

Looking Into Globus Medical's Recent Short Interest ↗

February 25, 2025

Via Benzinga

What Analysts Are Saying About Globus Medical Stock ↗

February 24, 2025

Via Benzinga

Here's How Much You Would Have Made Owning Globus Medical Stock In The Last 10 Years ↗

February 24, 2025

Via Benzinga

Earnings Scheduled For February 20, 2025 ↗

February 20, 2025

Via Benzinga

1 Mid-Cap Stock to Target This Week and 2 to Avoid

March 04, 2025

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from...

Via StockStory

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Siyata Mobile Inc. (Nasdaq - SYTA), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Nevro Corp. (NYSE – NVRO), 180 Degree Capital Corp. (Nasdaq – TURN)

February 26, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

Enovis (ENOV) Q4 Earnings: What To Expect

February 25, 2025

Medical technology company Enovis Corporation (NYSE:ENOV) will be announcing earnings results tomorrow before market open. Here’s what to expect.

Via StockStory

$100 Invested In Globus Medical 10 Years Ago Would Be Worth This Much Today ↗

February 10, 2025

Via Benzinga

Analyst Expectations For Globus Medical's Future ↗

February 06, 2025

Via Benzinga

Top 2 Health Care Stocks That May Crash In February ↗

February 05, 2025

Via Benzinga

Globus Medical (GMED) Q4 2024 Earnings Call Transcript ↗

February 20, 2025

GMED earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Globus Medical: Q4 Revenue Tops Forecast ↗

February 20, 2025

Globus Medical's robust earnings for Q4 2024 were driven by strategic acquisitions and sustained innovation.

Via The Motley Fool

Globus Medical’s (NYSE:GMED) Q4 Sales Beat Estimates

February 20, 2025

Medical device company Globus Medical (NYSE:GMED) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 6.6% year on year to $657.3 million. The company expects the full...

Via StockStory

Topics Earnings

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

February 20, 2025

From Globus Medical

Via GlobeNewswire

Why NYSE:GMED is Poised for High Growth. ↗

January 29, 2025

A fundamental and technical analysis of (NYSE:GMED): Exploring GLOBUS MEDICAL INC - A (NYSE:GMED)'s high growth characteristics.

Via Chartmill

Globus Medical (GMED) Q4 Earnings: What To Expect

February 19, 2025

Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results tomorrow after the bell. Here’s what to expect.

Via StockStory

Investors should take note of NYSE:GMED, a growth stock that remains attractively priced. ↗

February 07, 2025

Based on Fundamental Analysis it can be said that NYSE:GMED is a growth stock which is not overvalued.

Via Chartmill

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

February 06, 2025

From Globus Medical

Via GlobeNewswire

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

January 30, 2025

From Globus Medical

Via GlobeNewswire

Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 ↗

January 13, 2025

Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74.

Via Investor's Business Daily

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

January 08, 2025

From Globus Medical

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.